Breaking News Instant updates and real-time market news.

JBSAY

JBS S.A.

$12.97 /

+0.34 (+2.69%)

16:18
04/22/21
04/22
16:18
04/22/21
16:18

JBS S.A. initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Thiago Bortoluci initiated coverage of JBS S.A. with a Buy rating and R$41.30 price target, implying 24% potential upside. The company's portfolio diversification has helped it to navigate through animal protein cycles with "relatively stable" profitability, Bortoluci tells investors in a research note. The analyst expects U.S. beef to continue to support a positive earnings momentum.

TODAY'S FREE FLY STORIES

Initiation
Canaccord starts Tilray at Hold, says shares 'fully valued' » 09:54
05/06/21
05/06
09:54
05/06/21
09:54
TLRY

Tilray

$15.22 /

-0.69 (-4.34%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TLRY Tilray
$15.22 /

-0.69 (-4.34%)

TLRY Tilray
$15.22 /

-0.69 (-4.34%)

09:54 Today
Fly Intel: Top five analyst initiations
04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
TLRY Tilray
$15.22 /

-0.69 (-4.34%)

TLRY Tilray
$15.22 /

-0.69 (-4.34%)

TLRY Tilray
$15.22 /

-0.69 (-4.34%)

TLRY Tilray
$15.22 /

-0.69 (-4.34%)

Initiation
Fly Intel: Top five analyst initiations » 09:54
05/06/21
05/06
09:54
05/06/21
09:54
TLRY

Tilray

$15.22 /

-0.69 (-4.34%)

, FHS

First High-School Education

$6.77 /

+0.01 (+0.15%)

, CTIC

CTI BioPharma

$2.34 /

-0.01 (-0.43%)

, FRLN

Freeline

$11.40 /

+ (+0.00%)

, PAYA

Paya Holdings

$10.65 /

+0.06 (+0.57%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tilray (TLRY) initiated with a Buy at Canaccord. 2. First High-School Education (FHS) initiated with a Buy at Benchmark. 3. CTI BioPharma (CTIC) initiated with a Buy at Stifel. 4. Freeline (FRLN) initiated with a Buy at Guggenheim. 5. Paya Holdings (PAYA) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TLRY Tilray
$15.22 /

-0.69 (-4.34%)

FHS First High-School Education
$6.77 /

+0.01 (+0.15%)

CTIC CTI BioPharma
$2.34 /

-0.01 (-0.43%)

FRLN Freeline
$11.40 /

+ (+0.00%)

PAYA Paya Holdings
$10.65 /

+0.06 (+0.57%)

TLRY Tilray
$15.22 /

-0.69 (-4.34%)

04/28/21 BofA
Tilray reinstated with a Buy at BofA
04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
FHS First High-School Education
$6.77 /

+0.01 (+0.15%)

06:22 Today Benchmark
First High-School Education initiated with a Buy at Benchmark
CTIC CTI BioPharma
$2.34 /

-0.01 (-0.43%)

06:53 Today Stifel
CTI BioPharma initiated with a Buy at Stifel
01/04/21 Lake Street
CTI BioPharma price target raised to $13 from $8 at Lake Street
12/07/20 Lake Street
CTI BioPharma previewed 'new potential growth driver' at ASH, says Lake Street
10/22/20 Brookline
CTI BioPharma initiated with a Buy at Brookline
FRLN Freeline
$11.40 /

+ (+0.00%)

06:24 Today Guggenheim
Freeline initiated with a Buy at Guggenheim
03/22/21 Mizuho
Freeline initiated with a Buy at Mizuho
03/01/21 Stifel
Freeline initiated with a Buy at Stifel
11/25/20 Redburn
Freeline initiated with a Neutral at Redburn
PAYA Paya Holdings
$10.65 /

+0.06 (+0.57%)

05/05/21 Credit Suisse
Paya Holdings initiated with an Outperform at Credit Suisse
03/08/21 BTIG
Paya Holdings Q4 shows bull thesis intact, says BTIG
02/26/21 Raymond James
Paya Holdings initiated with an Outperform at Raymond James
02/23/21 DA Davidson
Paya Holdings initiated with a Buy at DA Davidson
TLRY Tilray
$15.22 /

-0.69 (-4.34%)

CTIC CTI BioPharma
$2.34 /

-0.01 (-0.43%)

PAYA Paya Holdings
$10.65 /

+0.06 (+0.57%)

  • 01
    Apr
  • 18
    Mar
  • 11
    Mar
  • 07
    Aug
TLRY Tilray
$15.22 /

-0.69 (-4.34%)

TLRY Tilray
$15.22 /

-0.69 (-4.34%)

FHS First High-School Education
$6.77 /

+0.01 (+0.15%)

CTIC CTI BioPharma
$2.34 /

-0.01 (-0.43%)

PAYA Paya Holdings
$10.65 /

+0.06 (+0.57%)

TLRY Tilray
$15.22 /

-0.69 (-4.34%)

PAYA Paya Holdings
$10.65 /

+0.06 (+0.57%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:54
05/06/21
05/06
09:54
05/06/21
09:54
PTON

Peloton

$82.29 /

-0.29 (-0.35%)

, FMC

FMC Corporation

$113.89 /

-8.07 (-6.62%)

, PFE

Pfizer

$38.30 /

-1.28 (-3.23%)

, OCFC

OceanFirst Financial

$22.86 /

-0.02 (-0.09%)

, PXD

Pioneer Natural

$163.40 /

-1.04 (-0.63%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Peloton (PTON) downgraded to Neutral from Buy at BofA with analyst Justin Post saying Peloton's voluntary recall of both the Tread and Tread+ treadmills change his "upside thesis," said Post, who said his biggest concern on the news is not the potential loss of Tread+ subscribers but the potential impact on the launch of the new lower-priced Tread, which he had previously anticipated would be a significant growth driver in FY22. 2. FMC Corporation (FMC) downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying the company reported a "somewhat weak quarter" in terms of organic growth. 3. Pfizer (PFE) downgraded to Neutral from Buy at Mizuho with analyst Vamil Divan saying the company delivered a "stunning beat and raise" in Q1, but the recent strength in the shares make meaningful upside more challenging. 4. OceanFirst Financial (OCFC) downgraded to Equal Weight from Overweight at Stephens with analyst Matt Breese saying despite a Q4 balance sheet restructuring that was expected to result in 15 basis points of net interest margin expansion, NIM disappointed in Q1 and the "pathway to a 1.00% ROA appears beyond 2022." 5. Pioneer Natural (PXD) downgraded to Hold from Buy at Truist with analyst Neal Dingmann noting that his rating change is driven by the "fear of change" in the "ever-changing energy investor appetite," even though the company's longer-term metrics are toward the top of the industry. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
PTON Peloton
$82.29 /

-0.29 (-0.35%)

FMC FMC Corporation
$113.89 /

-8.07 (-6.62%)

PFE Pfizer
$38.30 /

-1.28 (-3.23%)

PXD Pioneer Natural
$163.40 /

-1.04 (-0.63%)

PTON Peloton
$82.29 /

-0.29 (-0.35%)

05/05/21 BofA
Peloton downgraded to Neutral after 'thesis changing' recalls at BofA
05/05/21 BofA
Peloton downgraded to Neutral from Buy at BofA
05/05/21 BMO Capital
BMO Capital continues to worry Peloton shares will catch down to fundamentals
05/05/21 JPMorgan
JPMorgan sees Peloton shares remaining under pressure
FMC FMC Corporation
$113.89 /

-8.07 (-6.62%)

05:56 Today Citi
FMC Corporation downgraded to Neutral from Buy at Citi
02/11/21 Monness Crespi
FMC Corporation upgraded to Buy from Neutral at Monness Crespi
01/20/21 RBC Capital
FMC Corporation price target lowered to $136 from $145 at RBC Capital
01/20/21 Citi
Citi adds PPG to US Focus List, removes FMC
PFE Pfizer
$38.30 /

-1.28 (-3.23%)

06:02 Today Mizuho
Pfizer downgraded to Neutral from Buy at Mizuho
05/05/21 JPMorgan
Pfizer price target raised to $40 from $36 at JPMorgan
05/05/21 Barclays
Pfizer price target raised to $40 from $37 at Barclays
04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
OCFC OceanFirst Financial
$22.86 /

-0.02 (-0.09%)

07:16 Today Stephens
OceanFirst downgraded to Equal Weight at Stephens after NIM disappoints
06:22 Today Stephens
OceanFirst Financial downgraded to Equal Weight from Overweight at Stephens
03/24/21 Seaport Global
OceanFirst Financial initiated with a Buy at Seaport Global
03/24/21 Seaport Global
OceanFirst Financial initiated with a Buy at Seaport Global
PXD Pioneer Natural
$163.40 /

-1.04 (-0.63%)

08:22 Today Truist
Pioneer Natural downgraded to Hold from Buy at Truist
06:07 Today Truist
Pioneer Natural downgraded to Hold from Buy at Truist
04/23/21 Wolfe Research
Pioneer Natural downgraded to Peer Perform from Outperform at Wolfe Research
04/19/21 Truist
Pioneer Natural price target raised to $190 from $175 at Truist
PTON Peloton
$82.29 /

-0.29 (-0.35%)

FMC FMC Corporation
$113.89 /

-8.07 (-6.62%)

PFE Pfizer
$38.30 /

-1.28 (-3.23%)

OCFC OceanFirst Financial
$22.86 /

-0.02 (-0.09%)

PXD Pioneer Natural
$163.40 /

-1.04 (-0.63%)

PTON Peloton
$82.29 /

-0.29 (-0.35%)

PFE Pfizer
$38.30 /

-1.28 (-3.23%)

PXD Pioneer Natural
$163.40 /

-1.04 (-0.63%)

PTON Peloton
$82.29 /

-0.29 (-0.35%)

FMC FMC Corporation
$113.89 /

-8.07 (-6.62%)

PFE Pfizer
$38.30 /

-1.28 (-3.23%)

PXD Pioneer Natural
$163.40 /

-1.04 (-0.63%)

PTON Peloton
$82.29 /

-0.29 (-0.35%)

PFE Pfizer
$38.30 /

-1.28 (-3.23%)

PXD Pioneer Natural
$163.40 /

-1.04 (-0.63%)

Upgrade
Fly Intel: Top five analyst upgrades » 09:54
05/06/21
05/06
09:54
05/06/21
09:54
MELI

MercadoLibre

$1,510.00 /

-16.64 (-1.09%)

, DRI

Darden

$143.99 /

+1.79 (+1.26%)

, RARE

Ultragenyx

$115.51 /

+9.38 (+8.84%)

, QSR

Restaurant Brands

$69.50 /

+0.465 (+0.67%)

, ZNGA

Zynga

$10.42 /

+0.265 (+2.61%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MercadoLibre (MELI) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying the company reported another strong quarter as volume on the platform accelerated sequentially in Brazil and Mexico. 2. Darden (DRI) upgraded to Outperform from Market Perform at Cowen with analyst Andrew Charles saying the analyst believes Olive Garden sales in fiscal 2023 will "overpower" cost and labor headwinds to deliver above-consensus earnings. 3. Ultragenyx (RARE) upgraded to Outperform from In Line at Evercore ISI with analyst Liisa Bayko saying the shares have been under pressure as the Angelman program has been "slow to get back up and running," but management now has a good handle on what it will take to reinitiate the study, which should occur around the middle of this year with data updates by year-end. 4. Restaurant Brands (QSR) upgraded to Buy from Hold at Argus with analyst John Staszak saying the company's emphasis on drive-through purchases should boost revenue going forward. 5. Zynga (ZNGA) upgraded to Buy from Neutral at BofA with analyst Ryan Gee saying the company reported a "strong" Q1 result with "sustainable" double-digit organic growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
MELI MercadoLibre
$1,510.00 /

-16.64 (-1.09%)

DRI Darden
$143.99 /

+1.79 (+1.26%)

RARE Ultragenyx
$115.51 /

+9.38 (+8.84%)

QSR Restaurant Brands
$69.50 /

+0.465 (+0.67%)

ZNGA Zynga
$10.42 /

+0.265 (+2.61%)

MELI MercadoLibre
$1,510.00 /

-16.64 (-1.09%)

08:12 Today Credit Suisse
MercadoLibre price target lowered to $1,824 from $1,850 at Credit Suisse
05:26 Today Stifel
MercadoLibre upgraded to Buy from Hold at Stifel
05/03/21 Credit Suisse
MercadoLibre price target lowered to $1,850 from $1,925 at Credit Suisse
03/31/21 Wolfe Research
MercadoLibre initiated with an Outperform at Wolfe Research
DRI Darden
$143.99 /

+1.79 (+1.26%)

05:39 Today Cowen
Darden upgraded to Outperform from Market Perform at Cowen
04/12/21 JPMorgan
Darden price target raised to $162 from $150 at JPMorgan
03/31/21 Evercore ISI
Texas Roadhouse price target raised to $95 from $83 at Evercore ISI
03/31/21 Evercore ISI
Brinker price target raised to $80 from $66 at Evercore ISI
RARE Ultragenyx
$115.51 /

+9.38 (+8.84%)

05:58 Today Citi
Ultragenyx upgraded to Buy from Neutral at Citi
05/05/21 Evercore ISI
Evercore upgrades Ultragenyx with 'good handle' on Angelman program
05/05/21 Evercore ISI
Ultragenyx upgraded to Outperform from In Line at Evercore ISI
04/26/21 Credit Suisse
Ultragenyx assumed with a Neutral at Credit Suisse
QSR Restaurant Brands
$69.50 /

+0.465 (+0.67%)

07:42 Today Argus
Restaurant Brands upgraded to Buy from Hold at Argus
07:34 Today Argus
Restaurant Brands upgraded to Buy from Hold at Argus
05/03/21 Stephens
Restaurant Brands price target raised to $80 from $70 at Stephens
05/03/21 Truist
Restaurant Brands price target raised to $80 from $70 at Truist
ZNGA Zynga
$10.42 /

+0.265 (+2.61%)

06:14 Today BofA
Zynga upgraded to Buy from Neutral at BofA
06:03 Today BofA
Zynga upgraded to Buy from Neutral at BofA
04/22/21 Jefferies
Zynga assumed with a Buy at Jefferies
04/19/21 BMO Capital
Zynga initiated with an Outperform at BMO Capital
MELI MercadoLibre
$1,510.00 /

-16.64 (-1.09%)

DRI Darden
$143.99 /

+1.79 (+1.26%)

RARE Ultragenyx
$115.51 /

+9.38 (+8.84%)

QSR Restaurant Brands
$69.50 /

+0.465 (+0.67%)

ZNGA Zynga
$10.42 /

+0.265 (+2.61%)

  • 29
    Oct
  • 07
    Aug
QSR Restaurant Brands
$69.50 /

+0.465 (+0.67%)

ZNGA Zynga
$10.42 /

+0.265 (+2.61%)

MELI MercadoLibre
$1,510.00 /

-16.64 (-1.09%)

DRI Darden
$143.99 /

+1.79 (+1.26%)

QSR Restaurant Brands
$69.50 /

+0.465 (+0.67%)

ZNGA Zynga
$10.42 /

+0.265 (+2.61%)

DRI Darden
$143.99 /

+1.79 (+1.26%)

ZNGA Zynga
$10.42 /

+0.265 (+2.61%)

Hot Stocks
Glass Lewis recommends Adverum investors vote for Sonic board nominees » 09:53
05/06/21
05/06
09:53
05/06/21
09:53
ADVM

Adverum Biotechnologies

$3.62 /

-0.03 (-0.82%)

The Sonic Fund II, L.P.,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$3.62 /

-0.03 (-0.82%)

ADVM Adverum Biotechnologies
$3.62 /

-0.03 (-0.82%)

05/03/21 SVB Leerink
Adverum Biotechnologies downgraded to Market Perform at SVB Leerink
05/03/21 SVB Leerink
Adverum Biotechnologies downgraded to Market Perform from Outperform at SVB Leerink
04/29/21 Chardan
Chardan downgrades Adverum after serious adverse reaction disclosure
04/29/21 Chardan
Adverum Biotechnologies downgraded to Neutral from Buy at Chardan
ADVM Adverum Biotechnologies
$3.62 /

-0.03 (-0.82%)

  • 13
    Aug
ADVM Adverum Biotechnologies
$3.62 /

-0.03 (-0.82%)

Hot Stocks
At Home Group to be acquired by Hellman & Friedman for $2.8B, $36 per share » 09:49
05/06/21
05/06
09:49
05/06/21
09:49
HOME

At Home Group

$34.90 /

+3.65 (+11.68%)

At Home Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HOME At Home Group
$34.90 /

+3.65 (+11.68%)

HOME At Home Group
$34.90 /

+3.65 (+11.68%)

07:22 Today Wells Fargo
At Home Group price target raised to $37 from $30 at Wells Fargo
03/25/21 Loop Capital
At Home Group price target raised to $27 from $20 at Loop Capital
03/24/21 Wells Fargo
At Home Group price target raised to $30 from $25 at Wells Fargo
03/12/21 Monness Crespi
At Home Group price target raised to $33 from $28 at Monness Crespi
HOME At Home Group
$34.90 /

+3.65 (+11.68%)

  • 06
    Nov
HOME At Home Group
$34.90 /

+3.65 (+11.68%)

Hot Stocks
Kellogg says seeing good operating leverage » 09:47
05/06/21
05/06
09:47
05/06/21
09:47
K

Kellogg

$66.79 /

+3.69 (+5.85%)

Says Q1 cash flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
K Kellogg
$66.79 /

+3.69 (+5.85%)

K Kellogg
$66.79 /

+3.69 (+5.85%)

04/28/21 Deutsche Bank
Kellogg price target lowered to $70 from $75 at Deutsche Bank
04/07/21 Piper Sandler
Kellogg snack brands scored well in Piper Sandler teen survey
02/16/21 Citi
Kellogg price target lowered to $72 from $75 at Citi
01/19/21 JPMorgan
Kellogg price target lowered to $58 from $67 at JPMorgan
K Kellogg
$66.79 /

+3.69 (+5.85%)

K Kellogg
$66.79 /

+3.69 (+5.85%)

K Kellogg
$66.79 /

+3.69 (+5.85%)

Conference/Events
House Financial Services Committee to hold a virtual hearing » 09:47
05/06/21
05/06
09:47
05/06/21
09:47

The Committee holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Regis falls -14.5% » 09:47
05/06/21
05/06
09:47
05/06/21
09:47
RGS

Regis

$10.42 /

-1.62 (-13.46%)

Regis is down -14.5%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RGS Regis
$10.42 /

-1.62 (-13.46%)

RGS Regis
$10.42 /

-1.62 (-13.46%)

02/01/21
Regis upgraded to Buy at Loop Capital on margin expansion potential
02/01/21 Loop Capital
Regis upgraded to Buy from Hold at Loop Capital
01/22/21
Fly Intel: Top five analyst downgrades
01/22/21 Jefferies
Jefferies downgrades Regis to Hold on push out of franchise plan timeline
RGS Regis
$10.42 /

-1.62 (-13.46%)

RGS Regis
$10.42 /

-1.62 (-13.46%)

Hot Stocks
Fastly falls -17.8% » 09:47
05/06/21
05/06
09:47
05/06/21
09:47
FSLY

Fastly

$47.52 /

-10.375 (-17.92%)

Fastly is down -17.8%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$47.52 /

-10.375 (-17.92%)

FSLY Fastly
$47.52 /

-10.375 (-17.92%)

09:03 Today Craig-Hallum
Fastly price target lowered to $55 from $80 at Craig-Hallum
08:44 Today Oppenheimer
Fastly price target lowered to $85 from $110 at Oppenheimer
06:04 Today Piper Sandler
Fastly price target lowered to $45 from $65 at Piper Sandler
04/28/21
Fly Intel: Top five analyst downgrades
FSLY Fastly
$47.52 /

-10.375 (-17.92%)

  • 21
    May
FSLY Fastly
$47.52 /

-10.375 (-17.92%)

FSLY Fastly
$47.52 /

-10.375 (-17.92%)

FSLY Fastly
$47.52 /

-10.375 (-17.92%)

Hot Stocks
Quotient Technology falls -18.9% » 09:47
05/06/21
05/06
09:47
05/06/21
09:47
QUOT

Quotient Technology

$13.66 /

-3.21 (-19.03%)

Quotient Technology is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QUOT Quotient Technology
$13.66 /

-3.21 (-19.03%)

QUOT Quotient Technology
$13.66 /

-3.21 (-19.03%)

02/11/21 Craig-Hallum
Quotient Technology price target raised to $25 from $14 at Craig-Hallum
QUOT Quotient Technology
$13.66 /

-3.21 (-19.03%)

QUOT Quotient Technology
$13.66 /

-3.21 (-19.03%)

Hot Stocks
Ranpak Holdings rises 14.1% » 09:47
05/06/21
05/06
09:47
05/06/21
09:47
PACK

Ranpak Holdings

$22.98 /

+2.86 (+14.21%)

Ranpak Holdings is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PACK Ranpak Holdings
$22.98 /

+2.86 (+14.21%)

PACK Ranpak Holdings
$22.98 /

+2.86 (+14.21%)

04/26/21 Berenberg
Ranpak Holdings initiated with a Buy at Berenberg
04/19/21 Sidoti
Ranpak Holdings initiated with a Buy at Sidoti
PACK Ranpak Holdings
$22.98 /

+2.86 (+14.21%)

PACK Ranpak Holdings
$22.98 /

+2.86 (+14.21%)

Hot Stocks
Acushnet Holdings rises 14.7% » 09:47
05/06/21
05/06
09:47
05/06/21
09:47
GOLF

Acushnet Holdings

$49.12 /

+6.125 (+14.25%)

Acushnet Holdings is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOLF Acushnet Holdings
$49.12 /

+6.125 (+14.25%)

10/30/20 Roth Capital
Roth upgrades Acushnet to Buy on 'universally positive' golf metrics
10/30/20 Roth Capital
Acushnet Holdings upgraded to Buy from Neutral at Roth Capital
06/29/20 SunTrust
Acushnet Holdings, Callaway Golf price targets raised at SunTrust
05/27/20 Roth Capital
Acushnet Holdings downgraded to Neutral at Roth Capital after strong run
GOLF Acushnet Holdings
$49.12 /

+6.125 (+14.25%)

Hot Stocks
Sally Beauty rises 17.0% » 09:47
05/06/21
05/06
09:47
05/06/21
09:47
SBH

Sally Beauty

$23.62 /

+3.345 (+16.50%)

Sally Beauty is up 17.0%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBH Sally Beauty
$23.62 /

+3.345 (+16.50%)

SBH Sally Beauty
$23.62 /

+3.345 (+16.50%)

03/11/21 Oppenheimer
Sally Beauty downgraded to Perform from Outperform at Oppenheimer
01/21/21 Oppenheimer
Oppenheimer upgrades 'uniquely positioned' Freshpet to Outperform
01/20/21 Morgan Stanley
Sally Beauty upgraded to Equal Weight from Underweight at Morgan Stanley
06/04/20 Oppenheimer
Sally Beauty upgraded to Outperform at Oppenheimer
SBH Sally Beauty
$23.62 /

+3.345 (+16.50%)

SBH Sally Beauty
$23.62 /

+3.345 (+16.50%)

Hot Stocks
At Home Group to be acquired by Hellman & Friedman for $36 per share  09:46
05/06/21
05/06
09:46
05/06/21
09:46
HOME

At Home Group

$34.87 /

+3.615 (+11.57%)

 
ShowHide Related Items >><<
HOME At Home Group
$34.87 /

+3.615 (+11.57%)

HOME At Home Group
$34.87 /

+3.615 (+11.57%)

07:22 Today Wells Fargo
At Home Group price target raised to $37 from $30 at Wells Fargo
03/25/21 Loop Capital
At Home Group price target raised to $27 from $20 at Loop Capital
03/24/21 Wells Fargo
At Home Group price target raised to $30 from $25 at Wells Fargo
03/12/21 Monness Crespi
At Home Group price target raised to $33 from $28 at Monness Crespi
HOME At Home Group
$34.87 /

+3.615 (+11.57%)

  • 06
    Nov
HOME At Home Group
$34.87 /

+3.615 (+11.57%)

Hot Stocks
At Home Group to be acquired by Hellman & Friedman for $2.8B, including debt  09:45
05/06/21
05/06
09:45
05/06/21
09:45
HOME

At Home Group

$34.87 /

+3.615 (+11.57%)

 
ShowHide Related Items >><<
HOME At Home Group
$34.87 /

+3.615 (+11.57%)

HOME At Home Group
$34.87 /

+3.615 (+11.57%)

07:22 Today Wells Fargo
At Home Group price target raised to $37 from $30 at Wells Fargo
03/25/21 Loop Capital
At Home Group price target raised to $27 from $20 at Loop Capital
03/24/21 Wells Fargo
At Home Group price target raised to $30 from $25 at Wells Fargo
03/12/21 Monness Crespi
At Home Group price target raised to $33 from $28 at Monness Crespi
HOME At Home Group
$34.87 /

+3.615 (+11.57%)

  • 06
    Nov
HOME At Home Group
$34.87 /

+3.615 (+11.57%)

Conference/Events
Federal Reserve Bank of Cleveland President participates in a discussion » 09:45
05/06/21
05/06
09:45
05/06/21
09:45

Cleveland Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Aptorum Group, Exeltis to develop preclinical candidate for endometriosis » 09:45
05/06/21
05/06
09:45
05/06/21
09:45
APM

Aptorum Group

$2.64 /

+0.11 (+4.35%)

Aptorum Group has entered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APM Aptorum Group
$2.64 /

+0.11 (+4.35%)

APM Aptorum Group
$2.64 /

+0.11 (+4.35%)

07/13/20 Alliance Global Partners
Aptorum Group initiated with a Buy at Alliance Global Partners
APM Aptorum Group
$2.64 /

+0.11 (+4.35%)

APM Aptorum Group
$2.64 /

+0.11 (+4.35%)

Hot Stocks
Sodexo awarded contracts, extensions with U.S. Army MEDCOM, DeCA, Guam DOE » 09:44
05/06/21
05/06
09:44
05/06/21
09:44
SDXAY

Sodexo

$20.02 /

-0.165 (-0.82%)

Sodexo announced awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDXAY Sodexo
$20.02 /

-0.165 (-0.82%)

SDXAY Sodexo
$20.02 /

-0.165 (-0.82%)

04/15/21 Barclays
Sodexo price target raised to EUR 80 from EUR 74.50 at Barclays
04/12/21 UBS
Sodexo price target raised to EUR 95 from EUR 90 at UBS
02/22/21 UBS
Sodexo price target raised to EUR 90 from EUR 87.50 at UBS
02/12/21 Berenberg
Sodexo price target raised to EUR 86 from EUR 74 at Berenberg
Conference/Events
Federal Reserve Bank of New York to hold a webinar » 09:43
05/06/21
05/06
09:43
05/06/21
09:43

The Federal Reserve Bank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
TherapeuticsMD reports Q1 EPS (11c), consensus (12c) » 09:42
05/06/21
05/06
09:42
05/06/21
09:42
TXMD

TherapeuticsMD

$1.29 /

+ (+0.00%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TXMD TherapeuticsMD
$1.29 /

+ (+0.00%)

TXMD TherapeuticsMD
$1.29 /

+ (+0.00%)

01/28/21 H.C. Wainwright
TherapeuticsMD price target lowered to $4 from $5 at H.C. Wainwright
08/07/20 Jefferies
Jefferies downgrades 'show-me story' TherapeuticsMD to Underperform
08/07/20 Jefferies
TherapeuticsMD downgraded to Underperform from Hold at Jefferies
05/19/20
Fly Intel: Top five analyst downgrades
TXMD TherapeuticsMD
$1.29 /

+ (+0.00%)

  • 11
    Feb
  • 10
    Nov
TXMD TherapeuticsMD
$1.29 /

+ (+0.00%)

TXMD TherapeuticsMD
$1.29 /

+ (+0.00%)

Hot Stocks
At Home Group trading halted, news pending  09:42
05/06/21
05/06
09:42
05/06/21
09:42
HOME

At Home Group

$31.35 /

+0.1 (+0.32%)

 
ShowHide Related Items >><<
HOME At Home Group
$31.35 /

+0.1 (+0.32%)

HOME At Home Group
$31.35 /

+0.1 (+0.32%)

07:22 Today Wells Fargo
At Home Group price target raised to $37 from $30 at Wells Fargo
03/25/21 Loop Capital
At Home Group price target raised to $27 from $20 at Loop Capital
03/24/21 Wells Fargo
At Home Group price target raised to $30 from $25 at Wells Fargo
03/12/21 Monness Crespi
At Home Group price target raised to $33 from $28 at Monness Crespi
HOME At Home Group
$31.35 /

+0.1 (+0.32%)

  • 06
    Nov
HOME At Home Group
$31.35 /

+0.1 (+0.32%)

Hot Stocks
Lixiang Education Holding Company Ltd (ADS) trading resumes  09:42
05/06/21
05/06
09:42
05/06/21
09:42
LXEH

Lixiang Education

$8.75 /

+ (+0.00%)

 
ShowHide Related Items >><<
LXEH Lixiang Education
$8.75 /

+ (+0.00%)

  • 01
    Oct
Recommendations
Sykes Enterprises price target raised to $50 from $48 at Barrington » 09:42
05/06/21
05/06
09:42
05/06/21
09:42
SYKE

Sykes Enterprises

$42.65 /

+ (+0.00%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYKE Sykes Enterprises
$42.65 /

+ (+0.00%)

SYKE Sykes Enterprises
$42.65 /

+ (+0.00%)

02/25/21 Barrington
Sykes Enterprises price target raised to $48 from $46 at Barrington
01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
11/06/20 Barrington
Sykes Enterprises upgraded to Outperform from Market Perform at Barrington
09/22/20 Baird
Sykes Enterprises desiganted as a Fresh Pick at Baird
SYKE Sykes Enterprises
$42.65 /

+ (+0.00%)

Conference/Events
Federal Reserve Bank of Atlanta president participates in virtual event » 09:41
05/06/21
05/06
09:41
05/06/21
09:41

Atlanta Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.